Results 301 to 310 of about 315,728 (345)

Identification of immunogenic HLA-A*02:01 epitopes associated with HCC for immunotherapy development. [PDF]

Hepatol Commun
Maino A, Bourov A-Flin E, Decaens T, Khochbin S, Macek Jilkova Z, Rousseaux S, Plumas J, Saas P, Chaperot L, Manches O.   +9 more
europepmc   +1 more source

Leveraging mRNA technology for antigen based immuno-oncology therapies. [PDF]

J Immunother Cancer
Floudas CS, Sarkizova S, Ceccarelli M, Zheng W.   +3 more
europepmc   +1 more source

Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse model. [PDF]

Commun Med (Lond)
Renner TM, Stuible M, Rossotti MA, Rohani N, Cepero-Donates Y, Sauvageau J, Deschatelets L, Dudani R, Harrison BA, Baardsnes J, Koyuturk I, St Michael F, Hill JJ, Hemraz UD, Lenferink AEG, Tanha J, Fernandes B, Roldao A, McCluskie MJ, Akache B, Durocher Y.   +20 more
europepmc   +1 more source

Expression of Concern for Perlaza et al., "Immunogenicity of Four Plasmodium falciparum Preerythrocytic Antigens in Aotus lemurinus Monkeys". [PDF]

Infect Immun
American Society for Microbiology.
europepmc   +1 more source

The Path to Accessible Care: Development and Impact of Eculizumab Biosimilars for Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic Syndrome. [PDF]

BioDrugs
Jang JH, Han B, Jung J, Russo P, Kulasekararaj AG.   +4 more
europepmc   +1 more source

Design of methods assessing efficacy of antirabic vaccine prophylaxis

Терапевтический архив, 2004
V V Nedosekov, N A Zhdanova, Yu N Kurilchuk   +2 more
doaj